Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-24 @ 2:45 PM
NCT ID:
NCT01040559
Eligibility Criteria:
Inclusion Criteria:
* Hepatocellular carcinoma cytologically or histologically proved or diagnosed according the criteria of the American Association for the Study of Liver Diseases(AASLD 2005)
* Three nodules maximum (unilobar disease without limitation in the number of nodules; 3 maximum nodules if bilobar disease \[satellite nodules \<1cm not included in the total sum\])
* Child-Pugh score A or B7
* ECOG Performance Status \< 2
* Platelet count \> 50,000/µl and absolute neutrophil count (ANC) \>1,000/µl
* Serum creatinine \< 150 µmol/l
* Resting ejection fraction \> 50% (echocardiography or isotopic method)
* Age \> 18 years
* Signed written informed consent
Exclusion Criteria:
* Patients eligible for surgical resection or hepatic transplantation or radiofrequency ablation
* Extrahepatic metastases
* Known gastrointestinal bleeding up to 30 days before study entry
* Patients with anticoagulant treatment
* Evidence of portal vein thrombosis
* Pregnancy
* Clinically serious infection
* Known hypersensitivity to anthracyclines
* Known hypersensitivity to contrast medium
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01040559
Study Brief:
Protocol Section:
NCT01040559